nach oben

Journal of Neural Transmission

Erschienen in:

01.07.2014 | Neurology and Preclinical Neurological Studies - Original Article

The effects of 1 Hz rTMS preconditioned by tDCS on gait kinematics in Parkinson’s disease

verfasst von: Mitra von Papen, Mirabell Fisse, Anna-Sophia Sarfeld, Gereon R. Fink, Dennis A. Nowak

Erschienen in: Journal of Neural Transmission | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Hypokinetic gait is a common and very disabling symptom of Parkinson’s disease (PD). Repetitive transcranial magnetic stimulation (rTMS) over the motor cortex has been used with variable effectiveness to treat hypokinesia in PD. Preconditioning rTMS by transcranial direct current stimulation (tDCS) may enhance its effectiveness to treat hypokinetic gait in PD. Three-dimensional kinematic gait analysis was performed (1) prior to, (2) immediately after and (3) 30 min after low-frequency rTMS (1 Hz, 900 pulses, 80 % of resting motor threshold) over M1 contralateral to the more affected body side preconditioned by (1) cathodal, (2) anodal or (3) sham tDCS (amperage: 1 mA, duration: 10 min) in ten subjects with PD (7 females, mean age 63 ± 9 years) and ten healthy subjects (four females, mean age 50 ± 11 years). The effects of tDCS-preconditioned rTMS on gait kinematics were assessed by the following parameters: number of steps, step length, stride length, double support time, cadence, swing and stance phases. Our data suggest a bilateral improvement of hypokinetic gait in PD after 1 Hz rTMS over M1 of the more affected body side preceded by anodal tDCS. In contrast, 1 Hz rTMS alone (preceded by sham tDCS) and 1 Hz rTMS preceded by cathodal tDCS were ineffective to improve gait kinematics in PD. In healthy subjects, gait kinematics was unaffected by either intervention. Preconditioning motor cortex rTMS by tDCS is a promising approach to treat hypokinetic gait in PD.

Arias P, Vivas J, Grieve KL, Cudeiro J (2010) Controlled trial on the effect of 10 days low-frequency repetitive transcranial magnetic stimulation (rTMS) on motor signs in Parkinson’s disease. Mov Disord 25:1830–1838PubMedCrossRef

Avanzino L, Bove M, Trompetto C, Tacchino A, Ogliastro C, Abbruzzese G (2008) 1-Hz repetitive TMS over ipsilateral motor cortex influences the performance of sequential finger movements of different complexity. Eur J Neurosci 27:1285–1291PubMedCrossRef

Bäumer T, Hidding U, Hamel W, Buhmann C, Moll CK, Gerloff C, Orth M, Siebner HR, Münchau A (2009) Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson’s disease. Mov Disord 24:672–676PubMedCrossRef

Benninger DH, Berman BD, Houdayer E, Pal N, Luckenbaugh DA, Schneider L, Miranda S, Hallett M (2011) Intermittent theta-burst transcranial magnetic stimulation for treatment of Parkinson’s disease. Neurology 76:601–609PubMedCentralPubMedCrossRef

Benninger DH, Iseki K, Kranick S, Luckenbaugh DA, Houdayer E, Hallett M (2012) Controlled study of 50-Hz repetitive transcranial magnetic stimulation for treatment of Parkinson’s disease. Neurorehabil Neural Repair 26:1096–1105PubMedCrossRef

Benninger DH, Lomarev M, Lopez G, Wassermann EM, Li X, Considine E, Hallett M (2010) Transcranial direct current stimulation for the treatment of Parkinson’s disease. J Neurol Neurosurg Psychiatry 81:1105–1111PubMedCrossRef

Bestmann S, Baudewig J, Siebner HR, Rothwell JC, Frahm J (2004) Functional MRI of the immediate impact of transcranial magnetic stimulation on cortical and subcortical motor circuits. Eur J Neurosci 19:1950–1962PubMedCrossRef

Chen R, Classen J, Gerloff C, Celnik P, Wassermann EM, Hallett M, Cohen LG (1997) Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 48:1398–1403PubMedCrossRef

Dafotakis M, Grefkes C, Wang L, Fink GR, Nowak DA (2008) The effects of 1 Hz rTMS over the hand area of M1 on movement kinematics of the ipsilateral hand. J Neural Transm 115:1269–1274PubMedCrossRef

Elahi B, Elahi B, Chen R (2009) Effect of transcranial magnetic stimulation on Parkinson motor function-systematic review of controlled clinical trials. Mov Disord 24:357–363PubMedCrossRef

Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) The unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson’s disease, vol 2. McMillan Healthcare Information, Florham Park, pp 153–163

Fierro B, Brighina F, D’Amelio M, Daniele O, Lupo I, Ragonese P, Palermo A, Savettieri G (2008) Motor intracortical inhibition in PD: l-DOPA modulation of high-frequency rTMS effects. Exp Brain Res 184:521–528PubMedCrossRef

Filipović SR, Rothwell JC, Bhatia K (2010) Low-frequency repetitive transcranial magnetic stimulation and off-phase motor symptoms in Parkinson’s disease. J Neurol Sci 291(1–2):1–4PubMedCrossRef

Folstein MF, Folstein SE, McHugh PR (1975) Mini-Mental State (a practical method for grading the state of patients for the clinician). J Psychiatr Res 12:189–198PubMedCrossRef

Fregni F, Boggio PS, Santos MC, Lima M, Vieira AL, Rigonatti SP, Silva MT, Barbosa ER, Nitsche MA, Pascual-Leone A (2006) Noninvasive cortical stimulation with transcranial direct current stimulation in Parkinson’s disease. Mov Disord 21:1693–1702PubMedCrossRef

Ghabra MB, Hallett M, Wassermann EM (1999) Simultaneous repetitive transcranial magnetic stimulation does not speed fine movement in PD. Neurology 52:768–770PubMedCrossRef

González-García N, Armony JL, Soto J, Trejo D, Alegría MA, Drucker-Colín R (2011) Effects of rTMS on Parkinson’s disease: a longitudinal fMRI study. J Neurol 258:1268–1280PubMedCrossRef

Grüner U, Eggers C, Ameli M, Sarfeld AS, Fink GR, Nowak DA (2010) 1 Hz rTMS preconditioned by tDCS over the primary motor cortex in Parkinson’s disease: effects on bradykinesia of arm and hand. J Neural Transm 117:207–216PubMedCrossRef

Huang YY, Colino A, Selig DK, Malenka RC (1992) The influence of prior synaptic activity on the induction of long-term potentiation. Science 255:730–733PubMedCrossRef

Ikegeuchi M, Touge T, Nishiyama Y, Takeuchi H, Kuriyama S, Ohkawa M (2003) Effects of successive repetitive transcranial magnetic stimulation on motor performances and brain perfusion in idiopathic Parkinson’s disease. J Neurol Sci 209:41–46CrossRef

Khedr EM, Farweez HM, Islam H (2003) Therapeutic effect of repetitive transcranial magnetic stimulation on motor function in Parkinson’s disease patients. Eur J Neurol 10:567–572PubMedCrossRef

Khedr EM, Rothwell JC, Shawky OA, Ahmed MA, Hamdy A (2006) Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson’s disease. Mov Disord 21:2201–2205PubMedCrossRef

Kirkwood A, Rioult MC, Bear MF (1996) Experience-dependent modification of synaptic plasticity in visual cortex. Nature 381:526–528PubMedCrossRef

Kiss RM, Kocsis L, Knoll Z (2004) Joint kinematics and spatial–temporal parameters of gait measured by an ultrasound-based system. Med Eng Phys 26:611–620PubMedCrossRef

Knutsson E (1972) An analysis of Parkinsonian gait. Brain 95:475–486PubMedCrossRef

Kobayashi M (2010) Effect of slow repetitive TMS of the motor cortex on ipsilateral sequential simple finger movements and motor skill learning. Restor Neurol Neurosci 28:437–448PubMed

Krack P, Pollak P, Limousin P, Hoffmann D, Xie J, Benazzouz A (1998) Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson’s disease. Brain 121:141–147CrossRef

Lang N, Siebner HR, Ernst D, Nitsche MA, Paulus W, Lemon RN, Rothwell JC (2004) Preconditioning with transcranial direct current stimulation sensitizes the motor cortex to rapid-rate transcranial magnetic stimulation and controls the direction of after-effects. Biol Psychiatry 56:634–639PubMedCrossRef

Lang N, Siebner HR, Ward NS et al (2005) How does transcranial DC stimulation of the primary motor cortex alter regional neuronal activity in the human brain? Eur J Neurosci 22:495–504PubMedCentralPubMedCrossRef

Lefaucheur JP, Drouot X, Von Raison F, Ménard-Lefaucheur I, Cesaro P, Nguyen J-P (2004) Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson’s disease. Clin Neurophysiol 115:2530–2541PubMedCrossRef

Lomarev MP, Kanchana S, Bara-Jimenez W, Iyer M, Wassermann EM, Hallett M (2006) Placebo-controlled study of rTMS for the treatment of Parkinson’s disease. Mov Disord 21:325–331PubMedCrossRef

Lou JS, Benice T, Kearns G, Sexton G, Nutt J (2003) Levodopa normalizes exercise related cortico-motoneuron excitability abnormalities in Parkinson’s disease. Clin Neurophysiol 114:930–937PubMedCrossRef

Mak MK (2013) Repetitive transcranial magnetic stimulation combined with treadmill training can modulate corticomotor inhibition and improve walking performance in people with Parkinson’s disease. J Physiother 59:128PubMedCrossRef

Minks E, Mareček R, Pavlík T, Ovesná P, Bareš M (2011) Is the cerebellum a potential target for stimulation in Parkinson’s disease? Results of 1-Hz rTMS on upper limb motor tasks. Cerebellum 10:804–811PubMedCrossRef

Morris ME, Iansek R, Matyas TA, Summers JJ (1994) The pathogenesis of gait hypokinesia in Parkinson’s disease. Brain 117:1169–1181PubMedCrossRef

Nitsche MA, Kuo MF, Grosch J, Bergner C, Monte-Silva K, Paulus W (2009) D1-receptor impact on neuroplasticity in humans. J Neurosci 29:2648–2653PubMedCrossRef

Nitsche MA, Lampe C, Antal A, Liebetanz D, Lang N, Tergau F, Paulus W (2006) Dopaminergic modulation of long-lasting direct current-induced cortical excitability changes in the human motor cortex. Eur J Neurosci 23:1651–1657PubMedCrossRef

Nitsche MA, Paulus W (1997) Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol 15:633–639

Nitsche MA, Paulus W (2001) Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology 57:1899–1901PubMedCrossRef

Okabe S, Ugawa Y, Kanazawa I (2003) Effectiveness of rTMS on Parkinson’s Disease Study Group. 0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson’s disease. Mov Disord 18:382–388PubMedCrossRef

Pascual-Leone A, Valls-Sole J, Wassermann EM, Hallett M (1994) Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain 117:847–858PubMedCrossRef

Peppe A, Chiavalon C, Pasqualetti P, Crovato D, Caltagirone C (2007) Does gait analysis quantify motor rehabilitation efficacy in Parkinson’s disease patients? Gait Posture 26:452–462PubMedCrossRef

Rascol O, Sabatini U, Chollet F, Celsis P, Montastruc JL, Marc-Vergnes JP, Rascol A (1992) Supplementary and primary sensory motor area activity in Parkinson’s disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch Neurol 49:144–148PubMedCrossRef

Sabatini U, Boulanouar K, Fabre N, Martin F, Carel C, Colonnese C, Bozzao L, Berry I, Montastruc JL, Chollet F, Rascol O (2000) Cortical motor reorganization in akinetic patients with Parkinson’s disease: a functional MRI study. Brain 123:394–403PubMedCrossRef

Samuel M, Ceballos-Baumann AO, Blin J, Uema T, Boecker H, Passingham RE, Brooks DJ (1997) Evidence for lateral premotor and parietal overactivity in Parkinson’s disease during sequential and bimanual movements. A PET study. Brain 120:963–976PubMedCrossRef

Shirota Y, Ohtsu H, Hamada M, Enomoto H, Ugawa Y (2013) Research committee on rTMS treatment of Parkinson’s disease supplementary motor area stimulation for Parkinson’s disease: a randomized controlled study. Neurology 80:1400–1405PubMedCrossRef

Shimamoto H, Takasaki K, Shigemori M, Imaizumi T, Ayabe M, Shoji H (2001) Therapeutic effect and mechanism of repetitive transcranial magnetic stimulation in Parkinson’s disease. J Neurol 248:48–51CrossRef

Siebner HR, Lang N, Rizzo V, Nitsche MA, Paulus W, Lemon RN, Rothwell JC (2004) Preconditioning of low-frequency repetitive transcranial magnetic stimulation with transcranial direct current stimulation: evidence for homeostatic plasticity in the human motor cortex. J Neurosci 24:3379–3385PubMedCrossRef

Siebner HR, Rossmeier C, Mentschel C, Peinemann A, Conrad B (2000) Short-term motor improvement after sub-threshold 5-Hz repetitive transcranial magnetic stimulation of the primary motor hand area in Parkinson’s disease. J Neurol Sci 178:91–94PubMedCrossRef

Strafella AP, Ko JH, Grant J, Fraraccio M, Monchi O (2005) Corticostriatal functional interactions in Parkinson’s disease: a rTMS/[11C]raclopride PET study. Eur J Neurosci 22:2946–2952PubMedCentralPubMedCrossRef

Strafella AP, Paus T, Fraraccio M, Dagher A (2003) Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. Brain 126:2609–2615PubMedCrossRef

Tergau F, Wassermann EM, Paulus W, Ziemann U (1999) Lack of clinical improvement in patients with Parkinson’s disease after low and high frequency repetitive transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol Suppl 51:281–288

Yang YR, Tseng CY, Chiou SY, Liao KK, Cheng SJ, Lai KL, Wang RY (2013) Combination of rTMS and treadmill training modulates corticomotor inhibition and improves walking in Parkinson’s disease: a randomized trial. Neurorehabil Neural Repair 27:79–86PubMedCrossRef

Wu AD, Fregni F, Simon DK, Deblieck C, Pascual-Leone A (2008) Noninvasive brain stimulation for Parkinson’s disease and dystonia. Neurotherapeutics 5:345–361PubMedCentralPubMedCrossRef

Titel: The effects of 1 Hz rTMS preconditioned by tDCS on gait kinematics in Parkinson’s disease
verfasst von: Mitra von Papen
Mirabell Fisse
Anna-Sophia Sarfeld
Gereon R. Fink
Dennis A. Nowak
Publikationsdatum: 01.07.2014
Verlag: Springer Vienna
Erschienen in: Journal of Neural Transmission / Ausgabe 7/2014
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-014-1178-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2014

Deep brain stimulation of the amygdala alleviates fear conditioning-induced alterations in synaptic plasticity in the cortical–amygdala pathway and fear memory

Synergistic and additive effects of enriched environment and lithium on the generation of new cells in adult mouse hippocampus

Responsiveness to botulinum toxin type A in muscles of complex regional pain patients with tonic dystonia

IncobotulinumtoxinA (Xeomin®) can produce antibody-induced therapy failure in a patient pretreated with abobotulinumtoxinA (Dysport®)

An association between the reduced levels of SLC1A2 and GAD1 in the dorsolateral prefrontal cortex in major depressive disorder: possible involvement of an attenuated RAF/MEK/ERK signaling pathway